How many insider declarations has Sakhia, Samira filed?

Sakhia, Samira has filed 4 public insider declarations with SEDI.

What is Sakhia, Samira's role?

Sakhia, Samira's reported role is not specified by the regulator across the filings.

Which companies does Sakhia, Samira report trades for?

Sakhia, Samira reports trades for 2 companies, including Knight Therapeutics Inc..

What is Sakhia, Samira's declared buy vs sell volume?

Across the available history, declared buys total 13k€ and disposals 0.

← Executives ★ Sign in to follow

SS

Sakhia, Samira

OFFICER

·SEDI

Knight Therapeutics Inc.Dollarama Inc.

累计流向

0

申报总数

0

公司

€13,486

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the full record of transactions filed by Sakhia, Samira. Officer active across 2 companies, notably Knight Therapeutics Inc.. Cumulatively, 4 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €13k. History available since 15 June 2026. The latest transaction was filed on 7 August 2026 (35 - Stock dividend). Regulator: SEDI. The full history is free.

Companies and markets linked to Sakhia, Samira

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Knight Therapeutics Inc. (CA)Dollarama Inc. (CA)

申报4 总计

●

Sakhia, Samira

4 - Director of Issuer高管2026年8月7日Dollarama Inc.

CA$1,1480SEDI ↗

6 股@ CA$191.345Deferred Share Units (DSU)TSXSEDI:4763208

●

Sakhia, Samira

4 - Director of Issuer高管2026年8月3日Dollarama Inc.

0SEDI ↗

126 股Deferred Share Units (DSU)TSXSEDI:4760132

▲

Sakhia, Samira

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$3,75842SEDI ↗

720 股@ CA$5.220.0003% mcap17.2% 占其流量Common SharesTSXSEDI:4736911

标准退出：2026年9月13日 (T+90)

▲

Sakhia, Samira

4 - Director of Issuer, 5 - Senior Officer of Issuer高管2026年6月15日Knight Therapeutics Inc.

CA$18,10248SEDI ↗

1,934 股@ CA$9.360.0012% mcap82.8% 占其流量Common SharesTSXSEDI:4736910

标准退出：2026年9月13日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SS

Sakhia, Samira

OFFICER

·SEDI

Knight Therapeutics Inc.Dollarama Inc.

累计流向

0

申报总数

0

公司

€13,486

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the full record of transactions filed by Sakhia, Samira. Officer active across 2 companies, notably Knight Therapeutics Inc.. Cumulatively, 4 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €13k. History available since 15 June 2026. The latest transaction was filed on 7 August 2026 (35 - Stock dividend). Regulator: SEDI. The full history is free.